Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

Thrombotic events after COVID-19 vaccination in the over-50s: Results from a population-based study in Italy

Title: Thrombotic events after COVID-19 vaccination in the over-50s: Results from a population-based study in Italy
Authors: Baldi I.; Azzolina D.; Francavilla A.; Bartolotta P.; Lorenzoni G.; Vanuzzo D.; Gregori D.
Contributors: Baldi, I.; Azzolina, D.; Francavilla, A.; Bartolotta, P.; Lorenzoni, G.; Vanuzzo, D.; Gregori, D.
Publication Year: 2021
Collection: Università degli Studi di Ferrara: CINECA IRIS
Subject Terms: claims data; COVID-19; Vaxzevria; safety; adverse events; Italy
Description: Several European countries suspended or changed recommendations for the use of Vaxzevria (AstraZeneca) for suspected adverse effects due to atypical blood-clotting. This research aims to identify a reference point towards the number of thrombotic events expected in the Italian population over 50 years of age who received Vaxzevria from 22 January to 12 April 2021. The venous thromboembolism (VT) and immune thrombocytopenia (ITP) event rates were estimated from a population-based cohort. The overall VT rate was 1.15 (95% CI 0.93–1.42) per 1000 person-years, and the ITP rate was 2.7 (95% CI 0.7–11) per 100,000 person-years. These figures translate into 83 and two expected events of VT and ITP, respectively, in the 15 days following the first administration of Vaxzevria. The number of thrombotic events reported from the Italian Medicines Agency does not appear to have increased beyond that expected in individuals over 50 years of age.
Document Type: article in journal/newspaper
File Description: ELETTRONICO
Language: English
Relation: info:eu-repo/semantics/altIdentifier/pmid/34835237; info:eu-repo/semantics/altIdentifier/wos/WOS:000725588900001; volume:9; issue:11; firstpage:1307-1; lastpage:1307-5; numberofpages:5; journal:VACCINES; https://hdl.handle.net/11392/2486891
DOI: 10.3390/vaccines9111307
Availability: https://hdl.handle.net/11392/2486891; https://doi.org/10.3390/vaccines9111307; https://www.mdpi.com/2076-393X/9/11/1307
Rights: info:eu-repo/semantics/openAccess ; license:Creative commons ; license uri:http://creativecommons.org/licenses/by/4.0/
Accession Number: edsbas.9B519943
Database: BASE